LiteVax

Akkersestraat 50

4061Bj Ophemert

NL

LiteVax

Foundation date

24/05/2012

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

LiteVax BV is a biopharmaceutical company focusing on development and exploitation of innovative vaccine adjuvant concepts. Our mission is to contribute to global health by delivering improved adjuvants for vaccines against infectious and noninfectious diseases. People in developed and developing countries will benefit from better vaccines at lower costs.

Latest news

  • New software from UHasselt and ZEISS shows in sharp detail how biomolecules move in cells.

    22 hours ago

  • Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024

    23 hours ago

  • VIB-KU Leuven study reveals FUS protein’s role in ALS and FTD

    Friday June 14th 2024